UK – Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cance

The final draft guidance from NICE specifically recommends Nubeqa tablets in combination with androgen deprivation therapy (ADT) and docetaxel. The decision follows the Medicines and...

USA – Dual draft guidances outline FDA vision for pediatric drug development, exclusivity

In a move that could ruffle the feathers of pharmaceutical companies, the US Food and Drug Administration (FDA) says it aims to be more...
NICE ‘OK’ for Lynparza

UK – AstraZeneca’s heart failure treatment recommended by NICE for expanded use

Forxiga, sold as Farxiga in certain markets, has previously been recommended by NICE as a treatment option for HF patients with reduced ejection fraction...
NICE ‘OK’ for Lynparza

UK – MSD and Eisai’s combination therapy recommended by NICE for advanced endometrial cancer

The combination therapy is specifically indicated for adults with advanced or recurrent endometrial cancer whose disease has progressed on or after platinum-based chemotherapy and...

UK – AbbVie’s Rinvoq recommended by NICE for Crohn’s disease

The authorisation, which makes Rinvoq the first oral Janus Kinase (JAK) inhibitor available for this indication in England and Wales, specifically applies to patients...

Europe – Guidance for industry to prevent and mitigate medicine shortages

EMA has published recommendations for industry on good practices to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact . Medicine...
ANSM : Antibiotiques et Résistance Bactérienne : Une Menace Mondiale, des Conséquences Individuelles

France – Topiramate et risques chez les enfants exposés pendant la grossesse : modification...

Actualisation du 2 mai 2023 Depuis le 2 mai 2023, pour les filles, adolescentes, femmes en âge de procréer et femme enceintes : La prescription de...

Europe – EMA annual report 2022 published

EMA published its annual report 2022 today. The report provides an overview of the Agency’s activities to protect and promote public and animal health in the...

Europe – Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 – 12...

Review of hydroxyprogesterone started EMA has started a review of medicines containing hydroxyprogesterone following concerns about the safety and effectiveness of these medicines. In the...

Europe – Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling...

EMA’s safety committee, PRAC, is reminding healthcare professionals that the use of fluoroquinolone antibiotics, given by mouth, injection or inhalation, is restricted due to the...

NOS PROCHAINES FORMATIONS